Related Experiment Video

Updated: May 21, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids

O A Patutina1, N L Mironova, V V Vlassov

  • 1Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences.

Acta Naturae
|June 1, 2012
PubMed

Insights

Gene-targeted drugs like antisense oligonucleotides show promise in treating cancer by inhibiting oncogene expression. Their effectiveness varies based on the specific target gene and mRNA region, impacting tumor proliferation and invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Chemotherapy remains the primary cancer treatment but has limitations.
  • Novel therapeutic strategies are crucial for treating malignant tumors.
  • Gene-targeted drugs offer innovative approaches to inhibit oncogene expression.

Purpose of the Study:

  • To review experimental gene-targeted drugs for cancer treatment.
  • To present pre-clinical and clinical trial results of these novel therapies.
  • To analyze the efficacy of different gene-targeted drugs based on target genes.

Main Methods:

  • Review of experimental approaches using gene-targeted drugs.
  • Focus on antisense oligonucleotides (asON), small interfering RNA (siRNA), ribozymes, and DNAzymes.
  • Analysis of pre-clinical and early-stage clinical trial data.

Main Results:

  • Gene-targeted oligonucleotides demonstrated varied effects on tumor tissues.
  • Observed effects included inhibition of tumor cell proliferation and suppression of invasiveness.
  • Efficacy depended on the drug type and the specific mRNA target region.

Conclusions:

  • Gene-targeted drugs represent a promising avenue for cancer therapy.
  • The effectiveness of these drugs is highly specific to the target gene and mRNA sequence.
  • Further research is needed to optimize these novel therapeutic strategies.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.